PHYSIOLOGIC MECHANISMS OF BUPICOMIDE- AND HYDRALAZINE-INDUCED INCREASE IN PLASMA RENIN ACTIVITY IN HYPERTENSIVE PATIENTS.VELASCO M; MCNAY JL.1977; MAYO CLIN. PROC.; U.S.A.; DA. 1977; VOL. 52; NO 7-8; PP. 430-432; BIBL. 12 REF.Article

REGIONAL INCREASES IN MASS AND FLOW DURING COMPENSATORY RENAL HYPERTROPHY = AUGMENTATIONS REGIONALES DE LA MASSE ET DE LA CIRCULATION AU COURS DE L'HYPERTROPHIE RENALE COMPENSATRICEMCNAY JL; MIYAZAKI M.1973; AMER. J. PHYSIOL.; U.S.A.; DA. 1973; VOL. 224; NO 1; PP. 219-222; BIBL. 21 REF.Serial Issue

INTRARENAL MECHANISM FOR RENAL VASOCONSTRICTION RESULTING FROM STIMULATION OF THE URETER IN THE DOG.ROBIE NW; MCNAY JL.1978; CLIN. EXPER. PHARMACOL. PHYSIOL.; G.B.; DA. 1978; VOL. 5; NO 1; PP. 81-84; BIBL. 8 REF.Article

EFFECTS OF AZOTEMIA ON RENAL EXTRACTION AND CLEARANCE OF PAH AND TEA.MCNAY JL; ROSELLO S; DAYTON PG et al.1976; AMER. J. PHYSIOL.; U.S.A.; DA. 1976; VOL. 230; NO 4; PP. 901-906; BIBL. 25 REF.Article

EFFECT OF EXPERIMENTAL AZOTEMIA ON RENAL CLEARANCE OF FUROSEMIDE IN THE DOGROSE HJ; PRUITT AW; MCNAY JL et al.1976; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1976; VOL. 196; NO 1; PP. 238-247; BIBL. 27 REF.Article

COMPARATIVE EVALUATION OF THE HYPOTENSIVE ACTIVITY OF TWO MAJOR METABOLITES OF HYDRALAZINE (1-HYDRAZINOPHTHALAZINE).MCLEAN AJ; HAEGELE KD; DU SOUICH P et al.1977; EUROP. J. DRUG METABOL. PHARMACOKINET.; FR.; DA. 1977; VOL. 2; NO 1; PP. 17-20; BIBL. 20 REF.Article

CLINICAL PHARMACOKINETICS OF HYDRALAZINELUDDEN TM; MCNAY JL JR; SHEPHERD AMM et al.1982; CLIN. PHARMACOKINET.; ISSN 0312-5963; AUS; DA. 1982; VOL. 7; NO 3; PP. 185-205; BIBL. 4 P.Article

VASOCONSTRICTION LIMITS TO THE USE OF THE CENTRAL EAR ARTERY PRESSURE IN CONSCIOUS RABBITSTALSETH T; MCNAY JL; BALLINGER K et al.1981; LAB. ANIM. (LOND.); ISSN 0023-6772; GBR; DA. 1981; VOL. 15; NO 1; PP. 1-3; ABS. GER; BIBL. 6 REF.Article

HYDRALAZINE KINETICS AFTER SINGLE AND REPEATED ORAL DOSESSHEPHERD AMM; LUDDEN TM; MCNAY JL et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 6; PP. 804-811; BIBL. 30 REF.Article

HYDRALAZINE KINETICS IN HYPERTENSIVE PATIENTS AFTER INTRAVENOUS ADMINISTRATIONLUDDEN TM; SHEPHERD AMM; MCNAY JL et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 6; PP. 736-742; BIBL. 21 REF.Article

RELATIONSHIP OF URINARY FUROSEMIDE EXCRETION RATE TO NATRIURETIC EFFECT IN EXPERIMENTAL AZOTEMIA.ROSE HJ; PRUITT AW; DAYTON PG et al.1976; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1976; VOL. 199; NO 3; PP. 490-497; BIBL. 16 REF.Article

DECREASED PLASMA PROTEIN BINDING OF DIAZOXIDE IN UREMIA.O'MALLEY K; VELASCO M; PRUITT A et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 1; PP. 53-58; BIBL. 13 REF.Article

PHARMACODYNAMICS OF MONOXIDIL AS A GUIDE FOR INDIVIDUALIZING DOSAGE REGIMENS IN HYPERTENSIONSHEN D; O'MALLEY K; GIBALDI M et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 5; PP. 593-598; BIBL. 8REF.Article

CONTROL PLASMA RENIN ACTIVITY AND CHANGES IN SYMPATHETIC TONE AS DETERMINANTS OF MINOXIDIL-INDUCED INCREASE IN PLASMA RENIN ACTIVITY = L'ACTIVITE RENINE PLASMATIQUE TEMOIN ET LES MODIFICATIONS DU TONUS SYMPATHIQUE COMME FACTEURS DE L'AUGMENTATION DE L'ACTIVITE RENINE PLASMATIQUE (ARP) PROVOQUEE PAR LE MINOXIDILO'MALLEY K; VELASCO M; WELLS J et al.1975; J. CLIN. INVEST.; U.S.A.; DA. 1975; VOL. 55; NO 2; PP. 230-235; BIBL. 22 REF.Article

PHARMACOKINETICS AND CARDIOVASCULAR EFFECTS IN RABBITS OF A MAJOR HYDRALAZINE METABOLITE, THE HYDRALAZINE PYRUVIC-ACID HYDRAZONETALSETH T; HAEGELE KD; MCNAY JL et al.1979; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 211; NO 3; PP. 509-513; BIBL. 12 REF.Article

STUDY OF IN VITRO EFFECTS OF HYDRALAZINE METABOLITES. COMPARATIVE EVALUATION OF PRODUCTS OF HYDROXYLATION, HYDROLYSIS AND CONJUGATIONMCLEAN AJ; DU SOUICH P; BARRON K et al.1978; ARCH. INTERNATION. PHARMACODYN. THERAP.; BEL; DA. 1978; VOL. 235; NO 1; PP. 19-25; BIBL. 13 REF.Article

SULFADIAZINE HANDLING IN THE RABBIT. II. MECHANISMS OF NONLINEAR KINETICS OF ELIMINATIONDU SOUICH P; MCLEAN AJ; LALKA D et al.1978; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1978; VOL. 207; NO 1; PP. 228-235; BIBL. 26 REF.Article

BAROFLEX SENSITIVITY MODULATES VASODEPRESSOR RESPONSE TO NITROPRUSSIDESHEPHERD AMM; MIN SHUNG LIN; MCNAY JL et al.1983; HYPERTENSION (DALLAS); ISSN 0194-911X; USA; DA. 1983; VOL. 5; NO 1; PP. 79-85; BIBL. 43 REF.Article

DURATION OF HYDRALAZINE ACTION IN HYPERTENSION.O'MALLEY K; SEGAL JL; ISRAILI ZH et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 581-586; BIBL. 13 REF.Article

DIFFERENTIAL EFFECTS OF PROPRANOLOL ON HEART RATE AND PLASMA RENIN ACTIVITY IN PATIENTS TREATED WITH MINOXIDIL = EFFETS DIFFERENTIELS DU PROPRANOLOL SUR LA FREQUENCE CARDIAQUE ET L'ACTIVITE RENINE PLASMATIQUE CHEZ DES MALADES TRAITES PAR LE MINOXIDILVELASCO M; O'MALLEY K; ROBIE NW et al.1974; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1974; VOL. 16; NO 6; PP. 1031-1038; BIBL. 20 REF.Article

IMPROVED ASSAYS FOR HYDRALAZINE AND HYDRALAZINE PYRUVIC ACID HYDRAZONE IN HUMAN PLASMALUDDEN TM; LUDDEN LK; MCNAY JL et al.1980; ANAL. CHIM. ACTA; ISSN 0003-2670; NLD; DA. 1980; VOL. 120; NO 1; PP. 297-304; BIBL. 17 REF.Article

INTERACTION OF HYDRALAZINE AND HYDRAZONE DERIVATIVES WITH CONTRACTILE MECHANISMS IN RABBIT AORTIC SMOOTH MUSCLE.MCLEAN AJ; BARRON K; DU SOUICH P et al.1978; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1978; VOL. 205; NO 2; PP. 418-425; BIBL. 30 REF.Article

COMPARATIVE EVALUATION OF THE IN VITRO EFFECTS OF HYDRALAZINE AND HYDRALAZINE ACETONIDE ON ARTERIAL SMOOTH MUSCLE.BARRON K; CARRIER O; HAEGELE KD et al.1977; BRIT. J. PHARMACOL.; G.B.; DA. 1977; VOL. 61; NO 3; PP. 345-349; BIBL. 14 REF.Article

INITIAL EXPERIENCE OF CLINICAL PHARMACOLOGY AND CLINICAL PHARMACY INTERACTIONS IN A CLINICAL PHARMACOKINETICS CONSULTATION SERVICETAYLOR JW; MCLEAN AJ; LEONARD RG et al.1979; J. CLIN. PHARMACOL.; USA; DA. 1979; VOL. 19; NO 1; PP. 1-7; BIBL. 24 REF.Article